APT Medical is delighted to announce its participation in MLCTO 2026, taking place from June 24–27 in Nice, France. The congress brings together leading interventional cardiologists and experts in CTO and complex PCI to exchange clinical insights, refine procedural strategies, and advance contemporary practice.
As part of the scientific program, APT Medical will contribute to a series of educational activities designed to support real-world learning and facilitate peer-to-peer exchange in complex coronary intervention.
🔹 3rd MLCTO Academy Workshop
📅 June 24 | 12:00–15:00
APT Medical will participate in the 3rd MLCTO Academy Workshop, offering hands-on educational experience focused on CTO PCI strategies and device application. The session is designed to support practical learning through interactive discussion and case-based scenarios.
👉 Register here: https://academy.mlcto.com/3rd-workshop/
🔹 MLCTO Pre-congress Course (APT sponsored session)
📅 June 24 | 16:30–18:30
Moderated by Dr. Alexandre Avran, Board Member of MLCTO, this session will bring together six international CTO experts to share clinical experience, procedural refinement, and contemporary strategies for managing complex coronary lesions. The course emphasizes practical insights and real-world application in CTO PCI.
🔹 APT Sponsored Live Case Session
More details will be announced soon. This session will highlight real-world procedural applications of dedicated CTO solutions in complex clinical scenarios.
Learn more about the MLCTO program: https://course.mlcto.com/program-2026/
📍 Visit APT Medical at MLCTO 2026
Visitors are warmly invited to visit the APT booth to explore our comprehensive PCI portfolio, including solutions designed to support procedural precision, efficiency, and predictability in complex coronary interventions.
Hands-on demonstrations will also be available, allowing physicians to explore device application and contemporary CTO techniques through interactive simulation-based experience.
Advancing CTO PCI Together
Through participation in MLCTO 2026, APT Medical remains committed to supporting physician education and fostering collaboration within the global interventional cardiology community. By engaging in scientific exchange and hands-on training, we aim to contribute to continuous improvement in complex PCI practice and patient outcomes.